Although tumor burden in those BRAF V600E patients predicted a similar PFS, it did not reach statistical significance (Fig.
← all excerpts
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF</i> <sup><i>V600E</i></sup> mutation.
1
—
—